Neumora Therapeutics, Inc. (NMRA)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch NMRA
See up to 3 months of NMRA. The 7-day demo opens the 1M and 3M ranges and puts NMRA on your watchlist.
Start 7-day demoLatest NMRA insider trades
About Neumora Therapeutics, Inc. (NMRA)
Neumora Therapeutics, Inc. is an SEC registrant, filing under CIK 0001885522, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
NMRA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 11 | 453,833 | $702K |
| Grant or award | 5 | 1,750,000 | |
| Option exercise | 32 | 839,626 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
NMRA insider transactions (Form 4)
9128 Form 4 filings on record, the earliest from Oct 11, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 21,685 | $0.72 | $16K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 45,026 | $0.72 | $32K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 67,741 | $0.72 | $49K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 67,741 | $1.51 footnote F1 | $103K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 66,711 | $1.51 footnote F2 | $101K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 20,553 | $0.72 | $15K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 20,553 | $1.59 footnote F7 | $33K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 21,055 | $0.72 | $15K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 21,055 | $1.60 footnote F8 | $34K | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 67,741 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 45,026 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 21,685 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Grant or award | Stock Option (Right to Buy) | 200,000 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 20,553 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 21,055 | $0.00 | - | |
| ||||||
| Paul L. Berns - Officer | Grant or award | Stock Option (Right to Buy) | 500,000 | $0.00 | - | |
| Jason Duncan - Officer | Grant or award | Stock Option (Right to Buy) | 375,000 | $0.00 | - | |
 Michael Lee Milligan - Officer | Grant or award | Stock Option (Right to Buy) | 175,000 | $0.00 | - | |
| Joshua Pinto - Officer | Grant or award | Stock Option (Right to Buy) | 500,000 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 40,890 | $0.72 | $29K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 15,355 | $0.72 | $11K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 1,424 | $0.72 | $1K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 1 | $0.72 | $1 | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 57,670 | $1.51 footnote F1 | $87K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 34,020 | $1.49 footnote F2 | $51K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 25,279 | $0.72 | $18K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 29,737 | $0.72 | $21K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 55,016 | $1.50 footnote F4 | $83K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 34,162 | $0.72 | $25K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 34,162 | $1.58 footnote F9 | $54K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 34,987 | $0.72 | $25K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 34,987 | $1.59 footnote F10 | $55K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 13,268 | $0.72 | $10K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 17,732 | $0.72 | $13K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 31,000 | $1.65 footnote F11 | $51K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 30,918 | $0.72 | $22K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 30,918 | $1.65 footnote F12 | $51K | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 40,890 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 15,355 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 1,424 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 1 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 25,279 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 29,737 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 34,162 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 34,987 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 13,268 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 17,732 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 30,918 | $0.00 | - | |
| ||||||
| Kristina Burow | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
| Matthew K. Fust | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
 David Piacquad | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
| Alaa Halawa | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
 Maykin Ho | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 6,165 | $3.56 | $22K | |
| Joshua Pinto - Officer | Open-market sale | Common Stock | 5,967 | $3.54 | $21K | |
| Paul L. Berns - Officer | Open-market sale | Common Stock | 9,819 | $3.51 footnote F2 | $34K | |
| ||||||
| Michael Lee Milligan - Officer | Open-market sale | Common Stock | 1,436 | $3.57 | $5K | |
| Michael Lee Milligan - Officer | Grant or award | Stock Option (Right to Buy) | 350,000 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Grant or award | Stock Option (Right to Buy) | 750,000 | $0.00 | - | |
| Jason Duncan - Officer | Grant or award | Stock Option (Right to Buy) | 750,000 | $0.00 | - | |
| Joshua Pinto - Officer | Grant or award | Stock Option (Right to Buy) | 1,200,000 | $0.00 | - | |
| Paul L. Berns - Officer | Grant or award | Stock Option (Right to Buy) | 1,650,000 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 114,703 | $2.68 footnote F2 | $307K | |
| ||||||
| Kristina Burow - Director | Open-market purchase | Common Stock | 1,915,700 | $2.61 | $5.00M | |
| ARCH Venture Partners X, LLC - 10% Owner | Open-market purchase | Common Stock | 1,915,700 | $2.61 | $5.00M | |
| ARCH Venture Partners XII, LLC - 10% Owner | Open-market purchase | Common Stock | 1,915,700 | $2.61 | $5.00M | |
| Paul L. Berns - Officer | Derivative | Stock Option (Right to Buy) | 497,049 | - | - | |
| Paul L. Berns - Officer | Derivative | Stock Option (Right to Buy) | 955,864 | - | - | |
| Paul L. Berns - Officer | Derivative | Stock Option (Right to Buy) | 342,500 | - | - | |
| Paul L. Berns - Officer | Derivative | Stock Option (Right to Buy) | 2,000,000 | - | - | |
| Paul L. Berns - Officer | Grant or award | Stock Option (Right to Buy) | 497,049 | - | - | |
| Paul L. Berns - Officer | Grant or award | Stock Option (Right to Buy) | 955,864 | - | - | |
| Paul L. Berns - Officer | Grant or award | Stock Option (Right to Buy) | 342,500 | - | - | |
| Paul L. Berns - Officer | Grant or award | Stock Option (Right to Buy) | 2,000,000 | - | - | |
| Paul L. Berns | Gift | Common Stock | 133,097 | $0.00 | - | |
| Paul L. Berns | Gift | Common Stock | 133,097 | $0.00 | - | |
| Paul L. Berns | Gift | Common Stock | 133,097 | $0.00 | - | |
| Matthew K. Fust | Option exercise | Common Stock | 3,783 | $8.32 | $31K | |
| Matthew K. Fust | Option exercise | Common Stock | 1,800 | $8.79 | $16K | |
| Matthew K. Fust | Option exercise | Common Stock | 2,156 | $2.52 | $5K | |
| Matthew K. Fust | Open-market sale | Common Stock | 7,739 | $17.01 | $132K | |
| Matthew K. Fust | Option exercise | Common Stock | 6,205 | $8.79 | $55K | |
| Matthew K. Fust | Option exercise | Common Stock | 7,844 | $2.52 | $20K | |
| Matthew K. Fust | Open-market sale | Common Stock | 14,049 | $17.03 | $239K | |
| Matthew K. Fust | Option exercise | Stock Option (Right to Buy) | 3,783 | $0.00 | - | |
| Matthew K. Fust | Option exercise | Stock Option (Right to Buy) | 1,800 | $0.00 | - | |
| Matthew K. Fust | Option exercise | Stock Option (Right to Buy) | 2,156 | $0.00 | - | |
| Matthew K. Fust | Option exercise | Stock Option (Right to Buy) | 6,205 | $0.00 | - | |
| Matthew K. Fust | Option exercise | Stock Option (Right to Buy) | 7,844 | $0.00 | - | |
| Robert A. Lenz - Officer | Open-market sale | Common Stock | 5,563 | $15.01 | $84K | |
| Robert A. Lenz - Officer | Open-market sale | Common Stock | 8,260 | $15.09 | $125K | |
Item 2.02, 5.02, 9.01
Item 8.01, 9.01
Item 1.01, 2.03, 2.05, 7.01, 8.01, 9.01
Item 5.07
Recent NMRA Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Aurora Daljit Singh | Officer | 41,608 | $66K | View on EDGAR | |
| Aurora Daljit Singh | Officer | 134,452 |
NMRA insider trading FAQ
What is the latest insider trade for NMRA?
Neumora Therapeutics, Inc. (NMRA) had 6 insider filings in the last 90 days, with the most recent on 2026-08-21. The full record for NMRA runs to 28 Form 4 filings, the earliest from 2024-10-11. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NMRA stock?
No insider purchases of NMRA were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling NMRA stock?
11 insider sales of NMRA were filed in the last 90 days, totaling $702K.
Where can I see NMRA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NMRA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Daljit Singh Aurora view on EDGAR
- - Paul L. Berns view on EDGAR
- - Jason Duncan view on EDGAR
- - Michael Lee Milligan view on EDGAR
- - Joshua Pinto view on EDGAR
- - Daljit Singh Aurora view on EDGAR
- - Kristina Burow view on EDGAR
- - Matthew K. Fust view on EDGAR
- - David Piacquad view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where NMRA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NMRA with a 7-day demo
- NMRA on your watchlist
- Every NMRA Form 4 filing on record
- Up to 3 months of NMRA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
